stockrow
Friday 6 November 2026
Export QGEN’s income statement to Excel — free account
QIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
50.88
0.05
+0.10%
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Net income
QIAGEN N.V.'s net income for fiscal 2025 was $424.9M, up 408.3% from $83.6M in fiscal 2024. Over the twelve months to 30 June 2026 it was $409.3M. Over the past ten years it has ranged from −$41.5M (fiscal 2019) to $512.6M (fiscal 2021); the current reading is higher than 91% of that period. QIAGEN N.V. ranks 12th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $424.9M | 408.28% |
| FY2024 | $83.6M | (75.51%) |
| FY2023 | $341.3M | (19.35%) |
| FY2022 | $423.2M | (17.44%) |
| FY2021 | $512.6M | 42.71% |
| FY2020 | $359.2M | — |
| FY2019 | −$41.5M | — |
| FY2018 | $190.4M | 371.31% |
| FY2017 | $40.4M | (49.70%) |
| FY2016 | $80.3M | (38.18%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $103.4M | 51.96% |
| Mar 2026 | $68.0M | (36.90%) |
| Dec 2025 | $107.8M | (17.08%) |
| Sep 2025 | $130.0M | 35.11% |
| 42 more quarters | Free account |
Against its own ten years
Low −$41.5M
High $512.6M
Ten-year median
$190.4M
Current reading's percentile
91
Net income against peers
| Company | Net income |
|---|---|
| MEDP Medpace Holdings, Inc. compare | $517.8M |
| ICLR ICON PLC compare | $448.7M |
| QGEN QIAGEN N.V. | $409.3M |
| RVTY Revvity Inc. compare | $253.2M |
| BLLN BillionToOne, Inc. compare | $49.4M |
| CRL Charles River Laboratories International, Inc. compare | $42.6M |
| RDNT RadNet, Inc. compare | $19.3M |
| GRAL GRAIL, Inc. compare | −$406.2M |
| GH Guardant Health, Inc. compare | −$485.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on QGEN
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement